日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Human biomass movement exceeds the biomass movement of all land animals combined

人类生物量移动量超过所有陆地动物生物量移动量的总和。

Rosenberg, Yuval; Wiedenhofer, Dominik; Virág, Doris; Bar-Sella, Gabriel; Greenspoon, Lior; Herrnstadt, Barr; Akenji, Lewis; Phillips, Rob; Milo, Ron

USING AI APPROACHES FOR PREDICTING BRAIN AGEING CHANGES IN SCHIZOPHRENIA

利用人工智能方法预测精神分裂症患者的大脑衰老变化

Lewis Phillips, Gail D; Nishimura, Merry C; Lacap, Jennifer Arca; Kharbanda, Samir; Mai, Elaine; Tien, Janet; Malesky, Kimberly; Williams, Simon P; Marik, Jan; Phillips, Heidi S; Huang, *Lan-Ying; Hsiao, Han-Jung; Lin, Zong-Zhun; Chen, Chi-Wei; Chu, Yen-Wei

Utilising a non-surgical intervention in the knee osteoarthritis care pathway: a 6-year retrospective audit on NHS patients

在膝骨关节炎治疗路径中采用非手术干预:一项针对英国国家医疗服务体系(NHS)患者的6年回顾性审计

Benn, Robyn; Rawson, Lewis; Phillips, Amanda

RTK-Dependent Inducible Degradation of Mutant PI3Kα Drives GDC-0077 (Inavolisib) Efficacy

RTK依赖性诱导突变PI3Kα降解驱动GDC-0077(Inavolisib)疗效

Kyung W Song,Kyle A Edgar,Emily J Hanan,Marc Hafner,Jason Oeh,Mark Merchant,Deepak Sampath,Michelle A Nannini,Rebecca Hong,Lilian Phu,William F Forrest,Eric Stawiski,Stephen Schmidt,Nicholas Endres,Jane Guan,Jeffrey J Wallin,Jonathan Cheong,Emile G Plise,Gail D Lewis Phillips,Laurent Salphati,Timothy P Heffron,Alan G Olivero,Shiva Malek,Steven T Staben,Donald S Kirkpatrick,Anwesha Dey,Lori S Friedman

Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics

曲妥珠单抗不与大鼠或小鼠ErbB2/neu结合:对基于曲妥珠单抗的疗法的非临床安全性模型选择的影响

Lewis Phillips, Gail; Guo, Jun; Kiefer, James R; Proctor, William; Bumbaca Yadav, Daniela; Dybdal, Noel; Shen, Ben-Quan

Activity of trastuzumab emtansine (T-DM1) in 3D cell culture

曲妥珠单抗 emtansine (T-DM1) 在 3D 细胞培养中的活性

Jean Zheng Boyer, Gail D Lewis Phillips, Hiro Nitta, Karl Garsha, Brittany Admire, Robert Kraft, Eslie Dennis, Elizabeth Vela, Penny Towne

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

乳腺癌细胞对曲妥珠单抗获得性耐药的机制

Guangmin Li, Jun Guo, Ben-Quan Shen, Daniela Bumbaca Yadav, Mark X Sliwkowski, Lisa M Crocker, Jennifer A Lacap, Gail D Lewis Phillips

Stabilizing a Tubulysin Antibody-Drug Conjugate To Enable Activity Against Multidrug-Resistant Tumors

稳定微管溶素抗体-药物偶联物以使其对多药耐药肿瘤具有活性

Staben, Leanna R; Yu, Shang-Fan; Chen, Jinhua; Yan, Gang; Xu, Zijin; Del Rosario, Geoffrey; Lau, Jeffrey T; Liu, Luna; Guo, Jun; Zheng, Bing; Cruz-Chuh, Josefa Dela; Lee, Byoung-Chul; Ohri, Rachana; Cai, Wenwen; Zhou, Hongxiang; Kozak, Katherine R; Xu, Keyang; Lewis Phillips, Gail D; Lu, Jiawei; Wai, John; Polson, Andrew G; Pillow, Thomas H

Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapy

曲妥珠单抗 emtansine 和帕妥珠单抗双重靶向 HER2 阳性癌症:神经调节蛋白阻断在联合治疗的抗肿瘤反应中起着关键作用

Gail D Lewis Phillips, Carter T Fields, Guangmin Li, Donald Dowbenko, Gabriele Schaefer, Kathy Miller, Fabrice Andre, Howard A Burris 3rd, Kathy S Albain, Nadia Harbeck, Veronique Dieras, Diana Crivellari, Liang Fang, Ellie Guardino, Steven R Olsen, Lisa M Crocker, Mark X Sliwkowski

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2-positive breast cancers--role of estrogen receptor and HER2 reactivation

HER2 阳性乳腺癌对曲妥珠单抗和拉帕替尼产生不同耐药机制——雌激素受体和 HER2 再激活的作用

Yen-Chao Wang, Gladys Morrison, Ryan Gillihan, Jun Guo, Robin M Ward, Xiaoyong Fu, Maria F Botero, Nuala A Healy, Susan G Hilsenbeck, Gail Lewis Phillips, Gary C Chamness, Mothaffar F Rimawi, C Kent Osborne, Rachel Schiff